发明名称 CCR9 INHIBITORS AND METHODS OF USE THEREOF
摘要 The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
申请公布号 EP1507756(B1) 申请公布日期 2015.07.22
申请号 EP20030755422 申请日期 2003.05.21
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 FLEMING, PAUL;HARRIMAN, GERALDINE, C., B.;SHI, ZHAN;CHEN, SHAOWU
分类号 C07C311/14;A61K31/18;A61K31/381;A61K31/44;A61K31/4409;A61K31/4425;A61K31/444;A61K31/4965;A61K31/505;A61P1/04;A61P3/10;A61P5/14;A61P9/00;A61P9/10;A61P13/12;A61P17/00;A61P17/04;A61P17/06;A61P19/02;A61P21/00;A61P21/04;A61P25/28;A61P29/00;A61P37/06;A61P37/08;A61P43/00;C07C311/15;C07C311/21;C07C311/29;C07C311/44;C07C311/46;C07C317/34;C07C321/30;C07C323/49;C07D213/02;C07D213/30;C07D213/50;C07D213/65;C07D213/70;C07D213/71;C07D213/75;C07D213/76;C07D213/80;C07D213/89;C07D237/06;C07D237/08;C07D239/26;C07D239/42;C07D239/69;C07D333/34;C07D333/62;C07D405/06;C07D409/04;C07D409/06;C07D413/04;C07D413/14;C07D513/04 主分类号 C07C311/14
代理机构 代理人
主权项
地址